Standex International Corporation (SXI) Income Statement

The sequential acceleration from 2025Q4's 23.2% growth to 2026Q1's 27.6% suggests broad-based strength, though the deceleration to 8.1% in 2026Q3 may reflect tougher comps or moderating end-market demand. The consistent double-digit growth in recent quarters, despite a -7.7% dip in 2025Q1, points to a cyclical recovery that appears durable, but investors should monitor whether this pace is sustainable given the industrial cycle.

The 800 basis point expansion in gross margin over eight quarters is notable, but the 2026Q4 jump to 46.5% from 39.0% in the prior quarter appears anomalous, possibly due to product mix or a favorable settlement. Excluding that quarter, margins have hovered around 39-41%, suggesting structural improvement but not a step-change. This level exceeds peers like Curtiss-Wright (37.2%) and RBC Bearings (44.4%), indicating Standex's niche positioning supports premium pricing.

The dramatic swing in operating margin, particularly the 38.5% in 2026Q4, far exceeds the historical range and likely includes non-recurring gains, as SG&A remained relatively flat at $52.5M despite revenue growth. The 2026Q3 margin of 17.6% is more representative, still up from 12.6% a year earlier, indicating that fixed cost absorption is improving. However, the volatility in operating income suggests that investors should strip out one-off items to assess the underlying leverage.

The absence of R&D in the last five quarters, after $5.0M in 2024Q4, is striking for an industrial manufacturer and may indicate a shift to acquired technology or a focus on mature products. SG&A has remained relatively stable in absolute terms, ranging from $40.4M to $68.2M, but the 2025Q4 spike to $68.2M appears anomalous, possibly due to restructuring or litigation. Overall, cost discipline appears strong, but the lack of R&D could limit long-term innovation and competitive positioning.